Alzheimer's disease -related genes and pathways : special emphasis on seladin-1, [delta]opioid receptor 1 and BACE1
Year: 2011
Type: dissertation
Abstract: Alzheimer's disease (AD) is a complex and heterogeneous disorder with an evident genetic background.So far, mutations in three genes have been implicated in the familial, autosomal dominant form of AD with an early age of onset (< 65 years).These genes are APP encoding amyloid precursor protein and PSEN1 and PSEN2 encoding presenilin-1 or presenilin-2 proteins, respectively.On the other hand, a naturally occurring polymorphism, the Ή4 allele in the apolipoprotein E gene, (APOEȱΉ4), represents the major genetic risk factor for the development of both early-(EOAD) and late-onset (LOAD) forms of AD.Causative mutations in APP and PSEN genes explain less than 1% of all AD cases, while the vast majority of cases represent LOAD with a complex genetic inheritance.LOAD is considered to be caused by a combination of genetic, acquired, and environmental risk factors.Since the early nineties, nearly 700 individual susceptibility genes with low risk effects have been proposed as being to be associated with AD in various ethnic populations.Nonetheless, the underlying biological mechanisms of many of the risk genes in AD pathogenesis remain to be determined.This thesis aimed at exploring the molecular mechanisms of specific genes that have been postulated to genetically and/or functionally play a role in the pathogenesis of AD.The effects of these genes on the key pathways and processes relevant for AD pathogenesis, such as generation and accumulation of Ά-amyloid (AΆ), were investigated in different in vitro and in vivo models.In this thesis, the risk effects of the common risk gene polymorphisms were assessed in the Eastern Finnish sample cohort consisting of ~1300 AD patients and controls as well as in the familial AD sample set originating from USA.In addition, the role of different factors believed to be involved in AD pathogenesis, namely seladin-1, Έ-opioid receptor (ΈOR) and Ά-site APP cleaving enzyme 1 (BACE1), were examined in cultured human neuronal and non-neuronal cells as well as in the rat thalamus under conditions partially mimicking the cellular environment of the AD brain.In study I, single nucleotide polymorphisms (SNPs) in the candidate genes were selected for genotyping on the basis of the meta-analyses retrieved from the publically accessible AlzGene database.This study revealed SNPs in the tumor necrosis factor ΅ (TNF) and interleukin 1B (IL1B) genes, which genetically associated with AD in the Finnish case-control cohort and which also affected cerebrospinal fluid biomarker levels in AD patients.Study II revealed that under in vitro stress conditions, reduced seladin-1/DHCR24 expression resulted in enhanced GGA3 depletion in neuronal cells.GGA3 is a well-characterized BACE1 trafficking protein, which regulates the lysosomal degradation of BACE1.GGA3 depletion subsequently led to augmented post-translational stabilization of National Library of Medical Classification: WT 155, QU 470, QU 500, QU 55.7
Author: Timo Sarajärvi
Institution: University of Eastern Finland
Language: English
Subfield: Cellular and Molecular Neuroscience
Field: Neuroscience
Domain: Life Sciences
Open Access status: green
Award: G2719705196
OpenAlex ID: W3096219130
